KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Incyte (INCY) Other Operating Expenses: 2009-2024

Historic Other Operating Expenses for Incyte (INCY) over the last 16 years, with Dec 2024 value amounting to $330.8 million.

  • Incyte's Other Operating Expenses fell 20.66% to $86.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $115.3 million, marking a year-over-year decrease of 65.50%. This contributed to the annual value of $330.8 million for FY2024, which is 15.58% up from last year.
  • Per Incyte's latest filing, its Other Operating Expenses stood at $330.8 million for FY2024, which was up 15.58% from $286.2 million recorded in FY2023.
  • Incyte's 5-year Other Operating Expenses high stood at $330.8 million for FY2024, and its period low was $197.5 million during FY2020.
  • Over the past 3 years, Incyte's median Other Operating Expenses value was $286.2 million (recorded in 2023), while the average stood at $281.4 million.
  • Data for Incyte's Other Operating Expenses shows a peak YoY surged of 47.47% (in 2020) over the last 5 years.
  • Yearly analysis of 5 years shows Incyte's Other Operating Expenses stood at $197.5 million in 2020, then climbed by 2.65% to $202.8 million in 2021, then climbed by 12.02% to $227.1 million in 2022, then rose by 26.03% to $286.2 million in 2023, then increased by 15.58% to $330.8 million in 2024.